GA
RXRX icon

Guerra Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Guerra Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.88K Buy
+1,000
New +$5.25K ﹤0.01% 404

Other funds holding RXRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Guerra Advisors's RXRX Position: Q3 2025 in Review

Guerra Advisors opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2025: 1,000 shares worth $4.88K. The stake represents ﹤0.01% of the portfolio and ranks #404 among its holdings.

322 funds tracked by Wall St. Rank hold RXRX as of Q3 2025.

  • Guerra Advisors held 1,000 shares of Recursion Pharmaceuticals worth $4.88K as of Q3 2025.
  • Recursion Pharmaceuticals was a new Guerra Advisors position in Q3 2025.
  • Recursion Pharmaceuticals made up ﹤0.01% of Guerra Advisors's portfolio in Q3 2025, its #404 holding.
  • 322 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2025.

Based on Guerra Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.